FDA guidelines for payer, off-label communications: OK as long as 'truthful'

Two FDA guidance documents aim to help pharma companies show the value of their drugs to payers beyond what's included in FDA labeling.

from Most popular articles from Medical Marketing and Media https://ift.tt/2MstQe7